LSBio PathPlus Neuroscience Antibodies

Wednesday, 08 January, 2025 | Supplied by: Sapphire Bioscience

LSBio PathPlus Neuroscience Antibodies are suitable for immunohistochemistry (IHC) applications in neuroscience and neurobiology. Whether investigating neural development, neurodegenerative disorders or cancers of neural origin, the antibodies are designed to perform with high specificity and sensitivity.

The antibodies are billed as LSBio’s highest-quality molecular pathology IHC reagents, having been extensively tested and selected as the best-performing antibodies to each of the targets. This means they will perform in IHC with high sensitivity and specificity in formalin-fixed paraffin-embedded tissue samples.

The antibodies are distributed in Australia and New Zealand by Sapphire Bioscience.

Online: www.sapphirebioscience.com
Phone: 02 9698 2022

Content from other channels on our network

Government announces $1.1bn for cleaner fuel production

ABB Robotics invests in vision AI company

Green Gravity and Wollongong City sign MOU for clean energy innovation

Haigh's Chocolates opens new SA facility

Boral trials concrete with aggregates recarbonated via carbon capture

How will Australia's new climate targets impact manufacturing?

Award-winning design on Johnnie Walker Bottles uses digital inkjet technology

Krones expands its portfolio in process technology and can handling

Is the 'cocoa crisis' over for chocolate?

Philippines banana imports may pose biosecurity risk

Tyre recycling project addresses mining industry waste

How AI is empowering renewable energy in Australia

Australia's 2035 climate target announced

GECA–Rebuilt partnership to improve sustainability

Large-scale battery boom points to a cheaper power alternative

LSBio PathPlus Neuroscience Antibodies

Beckman Coulter Life Sciences IR820 and IR870 infrared dye antibody conjugates

AdipoGen Life Sciences PANoptosis research antibodies

Cytek 16-Color NK Cell Immunoprofiling Panel

Content from other channels on our network